Ransomware Intelligence

    Latest Research on INC and The Gentlemen Ransomware: Exposed AI Infrastructure

    Read the Research

    glenmarkpharma.com Ransomware Attack

    glenmarkpharma.comRansomed

    IndiaCountry
    Mar 25, 2026Discovered

    About this victim

    Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, India, is a global pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company operates in over 25 countries across North America, South America, Europe, Asia, Africa, and the Middle East, with a strong focus on research and development of innovative medications. Glenmark specializes in various therapeutic areas and maintains a diverse portfolio of pharmaceutical products serving both business and consumer markets worldwide. Rajeev Sharma Senior Vice President and Chief Financial Officer - North America Laura Lester Senior Vice President & General Counsel - North America Jim Brown Senior Vice President Firas B Abulaban Senior Vice President and Corporate Quality Head of North America Bradley Nowels Vice President Institutional Sales – North America Vishal Arora Vice President of Business Development and Licensing Michael Pope Executive Director and Site Head – Monroe, NC Adam Subervi Chief Compliance Officer Fabio Moreno Executive Director and Head of the OTC Business Kathleen (Kathy) McKenna Senior Director – Human Resources INVESTORS Company Secretary & Compliance Officer [email protected] Tel No.: +91 22 4018 9999 Fax No.: +91 22 4018 9986 REGISTRAR AND SHARE TRANSFER AGENTS KFIN Technologies Limited Selenium Building, Tower-B, Plot No 31 & 32,Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddy, Telangana, India – 500 032. Email ID: [email protected] Toll Free/ Phone Number : 1800 309 4001 WhatsApp Number : (91) 910 009 4099 KFINTECH Corporate Website: www.kfintech.com RTA Website: https://ris.kfintech.com Investor Support Centre (DIY Link) https://ris.kfintech.com/clientservices/isc BUSINESS DEVELOPMENT For queries related to collaboration and partnership, please email to : [email protected] INVESTORS Company Secretary & Compliance Officer [email protected] Tel No.: +91 22 4018 9999 ------------------------------------------- GRIEVANCE OFFICER [email protected] Tel No.: +91 22 4018 9999 Fax No.: +91 22 4018 9986 ------------------------------------------- REGISTRAR AND SHARE TRANSFER AGENTS KFIN Technologies Limited Selenium Building, Tower-B, Plot No 31 & 32,Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddy, Telangana, India – 500 032. Email ID: [email protected] Toll Free/ Phone Number : 1800 309 4001 WhatsApp Number : (91) 910 009 4099

    Domain

    glenmarkpharma.com

    Industry

    Manufacturing

    Country

    India

    Discovered

    8 months ago

    Confidence

    85%

    Severity

    Medium

    Status

    Claimed

    Threat group

    inc ransom

    Total victims

    531

    First seen

    Nov 2025

    Last seen

    Nov 2026

    Group status

    active

    Sophistication

    0

    Impact score

    129

    Threat level

    5.7/10
    Aggressiveness10/10
    Lethality2.9/10
    Criticality4.2/10

    Status breakdown

    Data Leaked4.1%22
    Negotiating1.7%9
    Claimed
    this victim
    94.2%500

    Victim's position within group

    Industry

    Manufacturing

    Known target sector

    Country

    India

    Frequently targeted country

    Group activity

    Monthly attacks · inc ransom

    531

    total · avg 40.8/mo